MFDS Announces Temporary Narcotics Classification for Seven Substances Including '1D-LSD'

The Ministry of Food and Drug Safety announced on the 16th its plan to designate seven substances, including '1D-LSD', as temporary narcotics.

1D-LSD contains components similar to the existing narcotic LSD and poses risks such as hallucinations. 'HHCP' (Hexahydrocannabinol) has a structure similar to 'Tetrahydrocannabinol' (THC), a cannabis component, and thus induces physical and psychological dependence. These two substances have been designated as Schedule 1 temporary narcotics.

Additionally, the Ministry announced the designation of five substances as Schedule 2 temporary narcotics: synthetic cannabis derivatives 'A-FUBIATA', 'A-PONASA', 'H4CBD', and benzodiazepine-related substances structurally similar to the psychotropic drug bromazepam, namely 'Desalkylgidazepam' and 'Gidazepam'.

These substances will be prohibited from possession, ownership, use, management, import/export, manufacture, sale, brokerage, and transfer as temporary narcotics until the end of 2026. Violations involving Schedule 1 temporary narcotics, such as import/export, manufacture, sale, or transfer, are punishable by life imprisonment or imprisonment of five years or more. For Schedule 2 temporary narcotics, import/export and manufacture are punishable by up to 10 years imprisonment or a fine of up to 100 million KRW, while sale or transfer is punishable by up to five years imprisonment or a fine of up to 50 million KRW.

Meanwhile, the temporary narcotics designation system manages substances that are not currently classified as narcotics but are abused as substitutes for narcotics and pose risks to public health, by regulating them as narcotics for up to three years.

This content was produced with the assistance of AI translation services.